Suppr超能文献

钒酸钠使胰岛素从逆向胞吞途径转向降解途径。

Shunting of insulin from a retroendocytotic pathway to a degradative pathway by sodium vanadate.

作者信息

Marshall S, Garvey W T, Monzon R

出版信息

J Biol Chem. 1987 Sep 5;262(25):12005-12.

PMID:3305500
Abstract

Adipocytes route internalized insulin through two major pathways, a degradative pathway and a retroendocytotic pathway. To examine whether sorting of incoming insulin-receptor complexes can be altered, we assessed the effect of vanadate on the intracellular processing of both insulin and insulin receptors. After cells were pretreated with vanadate (1 mM for 30 min at 37 degrees C), 125I-insulin was loaded into the cell interior. When the net efflux of insulin from cells into the medium was then monitored, vanadate was found to slow the efflux of insulin from a t1/2 of 6.2 min (controls) to 11 min. Since efflux reflects both the rapid extrusion of intact insulin and the slower release of degradative products, we proposed that vanadate diverts more insulin into the degradative pathway. Further evidence in support of this idea included the following: 1) when intracellular degradation of insulin was impaired by chloroquine, undegraded insulin accumulated faster within vanadate-treated cells, consistent with greater flux through a degradative pathway; 2) vanadate increased the percentage of degraded insulin released from cells from 61 and 72%; and 3) under steady-state binding conditions, more insulin resided in the cell interior of vanadate-treated cells (44.8% versus 34.5%), and the time required for the intracellular pool to reach equilibrium was prolonged (t1/2 of 5.5 min versus 4.0). Neither insulin internalization nor degradation was impaired by vanadate alone. In related studies Tris was found to inhibit insulin-mediated receptor recycling by only 10%, whereas in the presence of vanadate (plus Tris) almost all incoming insulin receptors were prevented from recycling. Vanadate alone had no effect on the ability of insulin receptors to recycle. Based on these results we conclude that: 1) vanadate shunts incoming insulin from a more rapid retroendocytotic pathway to a slower degradative pathway and diverts insulin receptors from a Tris-insensitive recycling pathway to one that can be completely inhibited by Tris; 2) these effects are selective, in that vanadate impairs neither insulin degradation nor receptor uptake and recycling. Considered together, these findings support the idea that a sorting mechanism exists for the intracellular routing of incoming insulin-receptor complexes.

摘要

脂肪细胞通过两条主要途径转运内化的胰岛素,一条是降解途径,另一条是逆向内吞途径。为了研究进入细胞的胰岛素受体复合物的分选是否可以改变,我们评估了钒酸盐对胰岛素和胰岛素受体细胞内加工过程的影响。在用钒酸盐(1 mM,37℃处理30分钟)预处理细胞后,将125I标记的胰岛素载入细胞内部。随后监测胰岛素从细胞向培养基中的净流出时,发现钒酸盐使胰岛素的流出速度减慢,半衰期从6.2分钟(对照组)延长至11分钟。由于流出既反映了完整胰岛素的快速排出,也反映了降解产物的较慢释放,我们推测钒酸盐使更多胰岛素进入降解途径。支持这一观点的进一步证据包括:1)当氯喹损害胰岛素的细胞内降解时,未降解的胰岛素在钒酸盐处理的细胞内积累得更快,这与通过降解途径的通量增加一致;2)钒酸盐使从细胞中释放的降解胰岛素的百分比从61%增加到72%;3)在稳态结合条件下,更多胰岛素存在于钒酸盐处理细胞的细胞内部(44.8%对34.5%),细胞内池达到平衡所需的时间延长(半衰期为5.5分钟对4.0分钟)。单独的钒酸盐既不损害胰岛素的内化也不损害其降解。在相关研究中发现,Tris仅抑制胰岛素介导的受体再循环10%,而在存在钒酸盐(加Tris)的情况下,几乎所有进入的胰岛素受体都被阻止再循环。单独的钒酸盐对胰岛素受体的再循环能力没有影响。基于这些结果,我们得出以下结论:1)钒酸盐将进入的胰岛素从较快的逆向内吞途径分流到较慢的降解途径,并将胰岛素受体从对Tris不敏感的再循环途径转移到可被Tris完全抑制的途径;2)这些作用具有选择性,因为钒酸盐既不损害胰岛素降解,也不损害受体摄取和再循环。综合考虑,这些发现支持了这样一种观点,即存在一种用于进入细胞的胰岛素受体复合物细胞内转运的分选机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验